Search

everythinglearnresearchcommunity

for

Search:↓

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Sodium valproate helps skin healing by affecting GABA and histone deacetylase.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Ficus benghalensis leaf extracts can effectively promote hair growth and inhibit hair loss.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The research found that the molecule lncRNA-H19 helps hair follicle cells grow by affecting certain cell pathways in cashmere goats.

Innovative methods are reducing animal testing and improving biomedical research.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Using PGPR as biofertilizers can improve soil health and plant growth while reducing reliance on synthetic fertilizers.

No definitive link between finasteride and male breast cancer, but further research is needed.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.